Revenue of $3.3 Million, a 12% Increase Compared to Prior Year ~~ Interim Analysis from MAINSAIL Study Reinforces Safety Profile, Effectiveness and Confirmation of Fusion ~~ Catamaran® SI Joint Fusion ...
Fully enrolled LORIKEET, a randomized 150-patient Phase 2 study of lorigerlimab in combination with docetaxel in patients with mCRPCInitiating ...
The event, held by Rep. Dan Meuser’s allies in a predominantly Black section of Philadelphia, was met with protests by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback